Ferring Receives U.S. FDA Approval for REBYOTA™ (fecal …
https://ferringusa.com/?press=ferring-receives-u-s-fda-approval-for-rebyota-fecal-microbiota-live-jslm-a-novel-first-in-class-microbiota-based-live-biotherapeutic
WebNov 30, 2022 · Saint-Prex, Switzerland and Parsippany, NJ, USA – 30 November, 2022 – Ferring Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approved REBYOTA ™ (fecal microbiota, live-jslm), a novel first-in-class microbiota-based live biotherapeutic indicated for the prevention of recurrence of Clostridioides difficile …
DA: 63 PA: 11 MOZ Rank: 31